Contact
Please use this form to send email to PR contact of this press release:
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)
TO:
Please use this form to send email to PR contact of this press release:
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)
TO: